Guo, Y., Wang, Z., Zhou, H., Pan, H., Han, W., Deng, Y., . . . Li, J. (2024). First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-12216-7
Chicago-referens (17:e uppl.)Guo, Ye, et al. "First-in-human Study of GFH018, a Small Molecule Inhibitor of Transforming Growth Factor-β Receptor I Inhibitor, in Patients with Advanced Solid Tumors." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-12216-7.
MLA-referens (9:e uppl.)Guo, Ye, et al. "First-in-human Study of GFH018, a Small Molecule Inhibitor of Transforming Growth Factor-β Receptor I Inhibitor, in Patients with Advanced Solid Tumors." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-12216-7.
